Brief introduction of Daqing biological headquarters

Beijing Daqing Biotechnology Co., Ltd. (hereinafter referred to as Daqing Biotechnology or Company) was established on 200 1, which is a high-tech enterprise founded by returned overseas students. Its headquarters is located at 70 1, Block B, Shangdi Jiahua Building, the core area of Zhongguancun Science Park. The legal representative is Mr. Li Cihui and the general manager is Mr. Li. Mainly engaged in the research and development, production, sales and service of biomedical materials, regenerative medicine and tissue engineering, stem cells and biotherapy products, it is one of the earliest enterprises engaged in the industrialization exploration of tissue engineering in China.

In 2006, Daqing Bio-West China Hospital became a strategic partner in the research and development of biomedical materials. At the same time, relying on the technological advantages of Tsinghua University Institute of Life Science and Medicine, Institute of Materials Science and Engineering, Department of Chemical Engineering and many research institutions, the company has integrated advanced technologies and resources at home and abroad and made many breakthroughs in the industrialization of related technologies. At present, the company has 7 national invention patents and a number of international advanced proprietary technologies, among which 10 patents are being applied, covering the fields of tissue engineering bones and tendons, natural medical repair materials, functional polymer medical materials and so on.

A new generation of high-tech products developed by the company, such as absorbable hemostatic membrane (Daqing bio-paper), allogenic bone repair material (bio-gold) and tooth desensitizer (Aominqing), obtained medical device registration certificates issued by SFDA in 2008, 201and 201respectively, and went on sale. At present, the company's tissue engineering products, such as tendon, cartilage and SIS, are undergoing clinical research at the national designated clinical experimental base, and three products are being registered and tested at the national designated China Institute for the Control of Pharmaceutical and Biological Products. At the same time, several series of products are under preclinical research and development. These products will make new contributions to the development of modern medical technology and the application of new medical materials in China with their international leading technology and quality advantages.

The company has a high-tech talent team composed of experts, professors, doctors and masters, including nearly ten experts with senior titles, and the proportion of bachelor degree or above reaches 72.6%. Since its establishment, the company has undertaken many scientific research tasks of the Ministry of Science and Technology, Beijing and Sichuan Province, and published more than 200 papers in professional academic magazines and conferences at home and abroad.